Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec:196:99-105.
doi: 10.1016/j.thromres.2020.08.032. Epub 2020 Aug 20.

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Affiliations

Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19

Leonard Naymagon et al. Thromb Res. 2020 Dec.

Abstract

Observational data suggest an acquired prothrombotic state may contribute to the pathophysiology of COVID-19. These data include elevated D-dimers observed among many COVID-19 patients. We present a retrospective analysis of admission D-dimer, and D-dimer trends, among 1065 adult hospitalized COVID-19 patients, across 6 New York Hospitals. The primary outcome was all-cause mortality. Secondary outcomes were intubation and venous thromboembolism (VTE). Three-hundred-thirteen patients (29.4%) died, 319 (30.0%) required intubation, and 30 (2.8%) had diagnosed VTE. Using Cox proportional-hazard modeling, each 1 μg/ml increase in admission D-dimer level was associated with a hazard ratio (HR) of 1.06 (95%CI 1.04-1.08, p < 0.0001) for death, 1.08 (95%CI 1.06-1.10, p < 0.0001) for intubation, and 1.08 (95%CI 1.03-1.13, p = 0.0087) for VTE. Time-dependent receiver-operator-curves for admission D-dimer as a predictor of death, intubation, and VTE yielded areas-under-the-curve of 0.694, 0.621, and 0.565 respectively. Joint-latent-class-modeling identified distinct groups of patients with respect to D-dimer trend. Patients with stable D-dimer trajectories had HRs of 0.29 (95%CI 0.17-0.49, p < 0.0001) and 0.22 (95%CI 0.10-0.45, p = 0.0001) relative to those with increasing D-dimer trajectories, for the outcomes death and intubation respectively. Patients with low-increasing D-dimer trajectories had a multivariable HR for VTE of 0.18 (95%CI 0.05-0.68, p = 0.0117) relative to those with high-decreasing D-dimer trajectories. Time-dependent receiver-operator-curves for D-dimer trend as a predictor of death, intubation, and VTE yielded areas-under-the-curve of 0.678, 0.699, and 0.722 respectively. Although admission D-dimer levels, and D-dimer trends, are associated with outcomes in COVID-19, they have limited performance characteristics as prognostic tests.

Keywords: Admission; COVID-19; D-dimer; Outcomes; Thrombosis; Trend.

PubMed Disclaimer

Conflict of interest statement

No funding was received for the preparation of this manuscript. The authors have no relevant conflicts of interest to report.

Figures

Fig. 1
Fig. 1
The results of joint latent class modeling (JLCM) of D-dimer trend and its association with the primary outcome of all-cause mortality are depicted. D-dimer level is expressed in units of μg/ml. The two distinct D-dimer trajectories (increasing and stable) are shown in the upper left corner. Survival curves for these two groups are shown in the upper-right corner. The results of Cox proportional hazards models are shown in the lower panel (* the multivariable model adjusted for race and anticoagulant use prior to diagnosis, as these were the only baseline characteristics different between groups). Abbreviations: CI – confidence interval; HR – hazard ratio.
Fig. 2
Fig. 2
The results of joint latent class modeling (JLCM) of D-dimer trend and its association with the secondary outcome of need for mechanical ventilation are depicted. D-dimer level is expressed in units of μg/ml. The two distinct D-dimer trajectories (increasing and stable) are shown in the upper left corner. Curves depicting proportion of patients not on mechanical ventilation over time are shown in the upper-right corner. The results of Cox proportional hazards models are shown in the lower panel (* the multivariable model adjusted for age, and Charlson Comorbidity Index, as these were the only baseline characteristics different between groups). Abbreviations: CI – confidence interval; HR – hazard ratio; MV – mechanical ventilation.
Fig. 3
Fig. 3
The results of joint latent class modeling (JLCM) of D-dimer trend and it association with the secondary outcome of diagnosed VTE are depicted. D-dimer level is expressed in units of μg/ml. The two distinct D-dimer trajectories (low-increasing and high-decreasing) are shown in the upper left corner. Curves depicting proportion of patients remaining venous-thrombosis-free over time are shown in the upper-right corner. The results of Cox proportional hazards models are shown in the lower panel (* the multivariable model adjusted for race as this was the only baseline characteristic different between groups). Abbreviations: CI – confidence interval; HR – hazard ratio.
Fig. 4
Fig. 4
A forest plot depicting the unadjusted and adjusted HRs (with corresponding 95% CIs) comparing D-dimer trajectories for each outcome of interest. HRs represent the hazard of event in the lower and more stable D-dimer group relative to the hazard of event in higher increasing D-dimer group. All depicted HRs were significant. Abbreviations: HR – hazard ratio; LCL – lower confidence limit; UCL – upper confidence limit.

References

    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 (ahead of print) - PubMed
    1. Tang N. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18(4):844–847. - PMC - PubMed
    1. Barrett C.D. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J. Thromb. Haemost. 2020 (ahead of print) - PMC - PubMed
    1. Zhang Y. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 2020;382(17):e38. - PMC - PubMed
    1. Dolhnikoff M. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J. Thromb. Haemost. 2020 (ahead of print) - PMC - PubMed

Publication types

Substances